Cerebellar Hemangioblastoma Differential Diagnosis

• Endoscopic Keyhole Approach Is Useful in the Diagnosis and Removal of Cystic Cerebellar Hemangioblastoma: A Case Report
• Optic nerve haemangioblastoma in association with von Hippel-Lindau syndrome: case report and literature review
• A Convolutional Neural Network Model for Distinguishing Hemangioblastomas From Other Cerebellar-and-Brainstem Tumors Using Contrast-Enhanced MRI
• Clinicopathological analysis of extraneural sporadic haemangioblastoma occurring in the tongue
• Polycythemia Secondary to Renal Hemangioblastoma: A Case Report and Literature Review
• Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI
• Intradural, extramedullary hemangioblastoma at the level of the conus medullaris: illustrative case
• Branch-like enhancement on contrast enhanced MRI is a specific finding of cerebellar lymphoma compared with other pathologies

The differential diagnosis for cerebellar hemangioblastoma, a vascular tumor commonly associated with von Hippel-Lindau disease, includes other posterior fossa masses and cystic lesions. Hemangioblastomas are typically cystic with a highly vascular enhancing mural nodule. Below are the main differential considerations:

—

Cerebellar Pilocytic Astrocytoma

1. Key Differences:
   1. Also cystic with an enhancing mural nodule.
   2. More common in children and young adults.
   3. Associated with glial markers on histology.
2. Distinguishing Features:
   1. Less vascular than hemangioblastoma.
   2. May show a more solid glial component on imaging.

Liu Z, Chen Q, Ren J, Ding L. Glioma located on the right cerebellar hemisphere misdiagnosed as hemangioblastoma: A case report. Asian J Surg. 2024 Nov 26:S1015-9584(24)02569-7. doi: 10.1016/j.asjsur.2024.10.235. Epub ahead of print. PMID: 39603947.

Cerebellar Metastases

1. Key Differences:
   1. Cystic brain metastases can mimic hemangioblastomas.
   2. Common primary sources include renal cell carcinoma (RCC), melanoma, and lung cancer.
2. Distinguishing Features:
   1. Often multiple lesions.
   2. Surrounding vasogenic edema.
3. Clinical Clues:
   1. History of systemic malignancy.

—

Posterior fossa ependymoma

1. Key Differences:
   1. Tends to arise near the fourth ventricle.
   2. May extend into the foramina of Luschka or Magendie.
2. Distinguishing Features:
   1. Calcifications may be present.
   2. Enhancement pattern is more heterogeneous.
   3. Associated with cerebrospinal fluid dissemination.

—

### 4. Medulloblastoma

1. Key Differences:
   1. WHO Grade IV tumor with high cellularity.
   2. Commonly arises in the midline (vermis) in children.
2. Distinguishing Features:
   1. Appears hyperdense on CT.
   2. Restricted diffusion on MRI.
3. Clinical Clues:
   1. Associated with hydrocephalus due to fourth ventricular obstruction.

—

### 5. Abscess

1. Key Differences:
   1. Ring-enhancing lesion with a cystic appearance.
   2. Central restricted diffusion on MRI (indicative of pus).
2. Clinical Clues:
   1. Fever, systemic infection, elevated inflammatory markers.

—

### 6. Atypical Teratoid/Rhabdoid Tumor (ATRT)

1. Key Differences:
   1. Aggressive tumor in young children (<3 years).
   2. May have cystic and solid components, mimicking hemangioblastoma.
2. Distinguishing Features:
   1. Shows restricted diffusion and heterogeneous enhancement.
   2. Associated with INI1/SMARCB1 gene mutations.

—

### 7. Brainstem Glioma

1. Key Differences:
   1. Rarely cystic; more commonly diffuse and infiltrative.
2. Distinguishing Features:
   1. Poorly circumscribed.
   2. Less enhancement compared to hemangioblastoma.

—

### 8. Cerebellar Cavernous Malformation

1. Key Differences:
   1. Well-defined vascular malformations.
   2. May present with a “popcorn-like” appearance on imaging due to hemosiderin deposition.
2. Distinguishing Features:
   1. Lack the cystic component and prominent mural nodule.
   2. Associated with susceptibility artifacts on gradient-echo MRI.

—

### 9. Epidermoid Cyst

1. Key Differences:
   1. Benign congenital lesion.
2. Distinguishing Features:
   1. Bright signal on diffusion-weighted imaging (DWI).
   2. No enhancement after contrast administration.

—

### 10. Choroid Plexus Papilloma

1. Key Differences:
   1. Can mimic hemangioblastomas when near the cerebellum.
   2. Highly vascular but arises from the choroid plexus.
2. Distinguishing Features:
   1. Homogeneous enhancement.
   2. Arises in proximity to the fourth ventricle.

—

### Key Imaging Features of Hemangioblastoma

1. MRI:
   1. Cystic lesion with a strongly enhancing mural nodule.
   2. Flow voids representing prominent vascular supply.
2. CT:
   1. Hypervascular mural nodule, with potential for intralesional hemorrhage.
3. Angiography:
   1. Demonstrates intense vascularity.
4. Spectroscopy:
   1. Elevated lipid/lactate peaks due to cystic components.

—

### Clinical Context

1. Hemangioblastoma: Strongly associated with von Hippel-Lindau syndrome.
2. Consider systemic screening for additional lesions (e.g., renal cysts, RCC, pancreatic cysts, pheochromocytomas).

—

Definitive diagnosis often requires histopathologic evaluation, particularly to distinguish hemangioblastomas from metastases or other cystic lesions with enhancing nodules.

General imaging differential considerations include:

brain metastases: although single posterior fossa metastases are uncommon they are still the most common diagnosis if the patient is middle-aged or older

Cerebellar glioma

Cerebellar astrocytoma

Cerebellar pilocytic astrocytoma in children

Cerebellar glioblastoma in adults

Posterior fossa ependymoma

arteriovenous malformation (AVM) with subacute bleed

cavernoma with subacute bleed

subacute infarction

medulloblastoma

common in childhood

much more solid

restricted diffusion (small round blue cell tumor)

Hemangioblastomas with enhanced cysts are often misdiagnosed by radiology because of their ring-enhanced nature. Computed tomography angiography may be the best modality for differentiating cerebellar HGlioblastoma from other ring-enhancing lesions ¹⁾.

Several primary pathologic entities in diverse anatomic locations have the potential to simulate metastatic neoplasms histologically. Their misinterpretation as such may result in needless and extensive clinical evaluations that are intended to detect a presumed malignancy at another site. More importantly, mistakes of this type can deprive patients of surgical excisions that could be curative ²⁾.

In adults with only cerebellar masses, cerebellar hemangioblastoma and cerebellar metastases are the 2 most important differential diagnoses.

High b value DWI reflects diffusion more accurately than does regular b value. Results showed that ADC calculation by high b value (b = 4000) DWI at 3-T magnetic resonance imaging is clinically useful for differentiating hemangioblastomas from brain metastases ³⁾.

Arterial spin labelled imaging can aid in distinguishing hemangioblastoma from metastases in patients with only cerebellar masses ⁴⁾.

Coexistence of hemangioblastomas and AVMs is extremely rare, and only 3 cases have been reported previously in the literature ⁵⁾.

To accurately distinguish HBs from other cerebellar-and-brainstem tumors using a convolutional neural network model based on a contrast-enhanced brain MRI dataset.

Study type: Retrospective.

Population: Four hundred five patients (182 = HBs; 223 = other cerebellar-and brainstem tumors): 305 cases for model training, and 100 for evaluation.

Field strength/sequence: 3 T/contrast-enhanced T1-weighted imaging (T1WI + C).

Assessment: A CNN-based 2D classification network was trained by using sliced data along the z-axis. To improve the performance of the network, we introduced demographic information, various data-augmentation methods and an auxiliary task to segment tumor region. Then, this method was compared with the evaluations performed by experienced and intermediate-level neuroradiologists, and the heatmap of deep feature, which indicates the contribution of each pixel to model prediction, was visualized by Grad-CAM for analyzing the misclassified cases.

Statistical tests: The Pearson chi-square test and an independent t-test were used to test for distribution difference in age and sex. And the independent t-test was exploited to evaluate the performance between experts and our proposed method. P value <0.05 was considered significant.

Results: The trained network showed a higher accuracy for identifying HBs (accuracy = 0.902 ± 0.031, F1 = 0.891 ± 0.035, AUC = 0.926 ± 0.040) than experienced (accuracy = 0.887 ± 0.013, F1 = 0.868 ± 0.011, AUC = 0.881 ± 0.008) and intermediate-level (accuracy = 0.827 ± 0.037, F1 = 0.768 ± 0.068, AUC = 0.810 ± 0.047) neuroradiologists. The recall values were 0.910 ± 0.050, 0.659 ± 0.084, and 0.828 ± 0.019 for the trained network, intermediate and experienced neuroradiologists, respectively. Additional ablation experiments verified the utility of the introduced demographic information, data augmentation, and the auxiliary-segmentation task.

The proposed method can successfully distinguish HBs from other cerebellar-and-brainstem tumors and showed diagnostic efficiency comparable to that of experienced neuroradiologists.

Evidence level: 3 TECHNICAL EFFICACY: Stage 2 ⁶⁾.

A clinical case of cerebellar hemangioblastoma with six years of evolution, which illustrates the diagnostic difficulties that often arise, especially when the clinical and imaging characteristics escape those usually described and when other clinical findings appear as confounding factors. A 17-year-old female was initially admitted to the emergency department (ED) with a holocranial headache, gait imbalance, and vomiting. A brain magnetic resonance imaging (MRI) was done and a rounded lesion was detected in the left cerebellar hemisphere, hypointense in T1 and hyperintense in T2, with annular contrast enhancement. Several hypotheses for diagnosis were made, and the patient was subjected to several therapies, with periods of remission of symptoms interleaved with periods of worsening. After imaging suggestive of hemangioblastoma on routine brain MRI, the tumor was excised surgically and the histopathology confirmed the diagnosis. In the control brain MRI exams performed six and 24 months after surgery, no evidence of tumor recurrence was detected, and the patient remained asymptomatic. In conclusion, although these are rare neoplasms, it is essential to always consider hemangioblastomas in the differential diagnosis of cases with compatible clinical and radiological findings. A wrong or late diagnosis may lead to the use of unnecessary and harmful therapies as well as the appearance of potentially preventable complications if these tumors are handled correctly and timely ⁷⁾